ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹9,042 Cr | ₹5,340 Cr | ₹5,527 Cr | ₹7,827 Cr | ₹7,861 Cr |
What is the latest Total Current Liabilities ratio of ZYDUS LIFESCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹9,042 Cr |
| Mar2024 | ₹5,340 Cr |
| Mar2023 | ₹5,527 Cr |
| Mar2022 | ₹7,827 Cr |
| Mar2021 | ₹7,861 Cr |
How is Total Current Liabilities of ZYDUS LIFESCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹9,042 Cr | 69.33 | |
| Mar2024 | ₹5,340 Cr | -3.38 | |
| Mar2023 | ₹5,527 Cr | -29.39 | |
| Mar2022 | ₹7,827 Cr | -0.44 | |
| Mar2021 | ₹7,861 Cr | - | |
Compare Total Current Liabilities of peers of ZYDUS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZYDUS LIFESCIENCES | ₹93,722.5 Cr | -0.5% | -0.5% | -4.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,068.0 Cr | -0.2% | 7.1% | 1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,847.0 Cr | 0.8% | -6% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,985.0 Cr | 1.2% | 6.4% | 13.1% | Stock Analytics | |
| CIPLA | ₹122,826.0 Cr | -0.2% | 1.4% | -0.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,418.0 Cr | 1.2% | 5.8% | 4.2% | Stock Analytics | |
ZYDUS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZYDUS LIFESCIENCES | -0.5% |
-0.5% |
-4.8% |
| SENSEX | 0% |
2.7% |
6.8% |
You may also like the below Video Courses